Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Annual Review of Medicine|August 16, 2022
Cystic Fibrosis Modulator TherapiesShijing Jia, Jennifer L Taylor-Cousar
Seminars in Respiratory and Critical Care Medicine|May 20, 2009
Hypoventilation in cystic fibrosisJennifer L Taylor-Cousar
Journal of Clinical Medicine|August 23, 2020
CFTR Modulators: Impact on Fertility, Pregnancy, and Lactation in Women with Cystic FibrosisJennifer L Taylor-Cousar
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 25, 2021
Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactationJennifer L Taylor-Cousar, Raksha Jain
Therapeutic Advances in Respiratory Disease|September 30, 2015
Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospectsKelly Kuk, Jennifer L Taylor-Cousar
Journal of Personalized Medicine|June 2, 2021
Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator EraRaksha Jain, Jennifer L Taylor-Cousar
European Respiratory Review : an Official Journal of the European Respiratory Society|March 22, 2020
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung diseaseMichal Shteinberg, Jennifer L Taylor-Cousar
Current Opinion in Pulmonary Medicine|August 22, 2021
Triple combination cystic fibrosis transmembrane conductance regulator modulator therapy in the real world - opportunities and challengesPeter J Barry, Jennifer L Taylor-Cousar
Expert Review of Respiratory Medicine|November 30, 2020
Development of elexacaftor - tezacaftor - ivacaftor: Highly effective CFTR modulation for the majority of people with Cystic FibrosisPeter G Middleton, Jennifer L Taylor-Cousar
Pageof 15